Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Uncovering β-relaxations in amorphous phase-change materials.

Peng SX, Cheng Y, Pries J, Wei S, Yu HB, Wuttig M.

Sci Adv. 2020 Jan 10;6(2):eaay6726. doi: 10.1126/sciadv.aay6726. eCollection 2020 Jan.

2.

[Characteristics and Mechanism of Monothioarsenate Adsorption on Sand, Sediment, and Goethite].

Liao DX, Shan HM, Peng SX, Pan AR, Huang J, Cheng H, Zhao CR.

Huan Jing Ke Xue. 2020 Jan 8;41(1):284-292. doi: 10.13227/j.hjkx.201905239. Chinese.

PMID:
31854929
3.

Predicting Complex Relaxation Processes in Metallic Glass.

Sun Y, Peng SX, Yang Q, Zhang F, Yang MH, Wang CZ, Ho KM, Yu HB.

Phys Rev Lett. 2019 Sep 6;123(10):105701. doi: 10.1103/PhysRevLett.123.105701.

PMID:
31573294
4.

[Responses of tree growth to artificial intervention on micro-topography in degraded woodland on hillslope].

Wang Z, Wang KQ, Zhao YY, Peng SX, Wang SB, Li K.

Ying Yong Sheng Tai Xue Bao. 2019 Aug;30(8):2583-2590. doi: 10.13287/j.1001-9332.201908.006. Chinese.

PMID:
31418181
5.

Anomalous nonlinear damping in metallic glasses: Signature of elasticity breakdown.

Peng SX, Zhang C, Yang C, Li R, Zhang T, Liu L, Yu HB, Samwer K.

J Chem Phys. 2019 Mar 21;150(11):111104. doi: 10.1063/1.5088184.

PMID:
30902016
6.

Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G1-S Checkpoint.

Zhu D, Xu S, Deyanat-Yazdi G, Peng SX, Barnes LA, Narla RK, Tran T, Mikolon D, Ning Y, Shi T, Jiang N, Raymon HK, Riggs JR, Boylan JF.

Mol Cancer Ther. 2018 Aug;17(8):1727-1738. doi: 10.1158/1535-7163.MCT-17-1084. Epub 2018 Jun 4.

7.

Corrigendum to "Intradiencephalon injection of histamine inhibited the recovery of locomotor function of spinal cord injured zebrafish" [Biochem. Biophys. Res. Comm. 489 (1) (2017) 275-280].

Huang SB, Zhao HD, Wang LF, Sun MF, Zhu YL, Wu YB, Xu YD, Peng SX, Cui C, Shen YQ.

Biochem Biophys Res Commun. 2017 Oct 21;492(3):528. doi: 10.1016/j.bbrc.2017.08.098. Epub 2017 Aug 31. No abstract available.

PMID:
28864060
8.

Associations of phthalates exposure with attention deficits hyperactivity disorder: A case-control study among Chinese children.

Hu D, Wang YX, Chen WJ, Zhang Y, Li HH, Xiong L, Zhu HP, Chen HY, Peng SX, Wan ZH, Zhang Y, Du YK.

Environ Pollut. 2017 Oct;229:375-385. doi: 10.1016/j.envpol.2017.05.089. Epub 2017 Jun 12.

PMID:
28614761
9.

Intradiencephalon injection of histamine inhibited the recovery of locomotor function of spinal cord injured zebrafish.

Huang SB, Zhao HD, Wang LF, Sun MF, Zhu YL, Wu YB, Xu YD, Peng SX, Cui C, Shen YQ.

Biochem Biophys Res Commun. 2017 Jul 29;489(3):275-280. doi: 10.1016/j.bbrc.2017.05.158. Epub 2017 May 27. Erratum in: Biochem Biophys Res Commun. 2017 Oct 21;492(3):528.

PMID:
28559136
10.

Synthesis and evaluation of 2-cyano-3, 12-dioxooleana-1, 9(11)-en-28-oate-13β, 28-olide as a potent anti-inflammatory agent for intervention of LPS-induced acute lung injury.

Mou Y, Jian YL, Chen T, Huang ZJ, Qiao YX, Peng SX, Zhang DY, Ji H, Zhang YH.

Chin J Nat Med. 2017 May;15(5):347-354. doi: 10.1016/S1875-5364(17)30055-9.

PMID:
28558870
11.

Semaphorin4D promotes axon regrowth and swimming ability during recovery following zebrafish spinal cord injury.

Peng SX, Yao L, Cui C, Zhao HD, Liu CJ, Li YH, Wang LF, Huang SB, Shen YQ.

Neuroscience. 2017 May 20;351:36-46. doi: 10.1016/j.neuroscience.2017.03.030. Epub 2017 Mar 25.

PMID:
28347780
12.

Unexpected Neuroprotective Effects of Loganin on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurotoxicity and Cell Death in Zebrafish.

Yao L, Peng SX, Xu YD, Lin SL, Li YH, Liu CJ, Zhao HD, Wang LF, Shen YQ.

J Cell Biochem. 2017 Mar;118(3):615-628. doi: 10.1002/jcb.25749. Epub 2016 Oct 12.

PMID:
27662601
13.

Study on space charge compensation in negative hydrogen ion beam.

Zhang AL, Peng SX, Ren HT, Zhang T, Zhang JF, Xu Y, Guo ZY, Chen JE.

Rev Sci Instrum. 2016 Feb;87(2):02B915. doi: 10.1063/1.4932557.

PMID:
26932087
14.

Duty factor variation possibility from 1% to 100% with PKU microwave driven Cs-free volume H⁻ sources.

Peng SX, Zhang T, Ren HT, Zhang AL, Xu Y, Zhang JF, Guo ZY, Chen JE.

Rev Sci Instrum. 2016 Feb;87(2):02B125. doi: 10.1063/1.4934816.

PMID:
26932007
15.

Improvements of PKU PMECRIS for continuous hundred hours CW proton beam operation.

Peng SX, Zhang AL, Ren HT, Zhang T, Zhang JF, Xu Y, Guo ZY, Chen JE.

Rev Sci Instrum. 2016 Feb;87(2):02A706. doi: 10.1063/1.4932399.

PMID:
26931924
16.

Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115.

Mortensen DS, Perrin-Ninkovic SM, Shevlin G, Elsner J, Zhao J, Whitefield B, Tehrani L, Sapienza J, Riggs JR, Parnes JS, Papa P, Packard G, Lee BG, Harris R, Correa M, Bahmanyar S, Richardson SJ, Peng SX, Leisten J, Khambatta G, Hickman M, Gamez JC, Bisonette RR, Apuy J, Cathers BE, Canan SS, Moghaddam MF, Raymon HK, Worland P, Narla RK, Fultz KE, Sankar S.

J Med Chem. 2015 Jul 23;58(14):5599-608. doi: 10.1021/acs.jmedchem.5b00627. Epub 2015 Jul 8.

PMID:
26102506
17.

Discovery of mammalian target of rapamycin (mTOR) kinase inhibitor CC-223.

Mortensen DS, Perrin-Ninkovic SM, Shevlin G, Zhao J, Packard G, Bahmanyar S, Correa M, Elsner J, Harris R, Lee BG, Papa P, Parnes JS, Riggs JR, Sapienza J, Tehrani L, Whitefield B, Apuy J, Bisonette RR, Gamez JC, Hickman M, Khambatta G, Leisten J, Peng SX, Richardson SJ, Cathers BE, Canan SS, Moghaddam MF, Raymon HK, Worland P, Narla RK, Fultz KE, Sankar S.

J Med Chem. 2015 Jul 9;58(13):5323-33. doi: 10.1021/acs.jmedchem.5b00626. Epub 2015 Jun 26.

PMID:
26083478
18.

CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization.

Mortensen DS, Fultz KE, Xu S, Xu W, Packard G, Khambatta G, Gamez JC, Leisten J, Zhao J, Apuy J, Ghoreishi K, Hickman M, Narla RK, Bissonette R, Richardson S, Peng SX, Perrin-Ninkovic S, Tran T, Shi T, Yang WQ, Tong Z, Cathers BE, Moghaddam MF, Canan SS, Worland P, Sankar S, Raymon HK.

Mol Cancer Ther. 2015 Jun;14(6):1295-305. doi: 10.1158/1535-7163.MCT-14-1052. Epub 2015 Apr 8.

19.

GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers.

McLeod JF, Leempoels JM, Peng SX, Dax SL, Myers LJ, Golder FJ.

Br J Anaesth. 2014 Nov;113(5):875-83. doi: 10.1093/bja/aeu182. Epub 2014 Jul 2.

20.

Handling radiation generated during an ion source commissioning.

Ren HT, Zhao J, Peng SX, Lu PN, Zhou QF, Xu Y, Chen J, Zhang T, Zhang AL, Guo ZY, Chen JE.

Rev Sci Instrum. 2014 Feb;85(2):02A930. doi: 10.1063/1.4833925.

PMID:
24593509
21.

Plasma studies of the permanent magnet electron cyclotron resonance ion source at Peking University.

Ren HT, Peng SX, Xu Y, Zhao J, Lu PN, Chen J, Zhang AL, Zhang T, Guo ZY, Chen JE.

Rev Sci Instrum. 2014 Feb;85(2):02A927. doi: 10.1063/1.4832065.

PMID:
24593506
22.

Commissioning and operation of the deuteron injector for PKUNIFTY project.

Ren HT, Peng SX, Lu PN, Zhao J, Zhou QF, Song ZZ, Yuan ZX, Yu JX, Guo ZY, Chen JE.

Rev Sci Instrum. 2014 Feb;85(2):02A706. doi: 10.1063/1.4826337.

PMID:
24593440
23.

Intense beams from gases generated by a permanent magnet ECR ion source at PKU.

Ren HT, Peng SX, Lu PN, Yan S, Zhou QF, Zhao J, Yuan ZX, Guo ZY, Chen JE.

Rev Sci Instrum. 2012 Feb;83(2):02B905. doi: 10.1063/1.3669788.

PMID:
22380337
24.

Deuteron injector for Peking University Neutron Imaging Facility project.

Ren HT, Peng SX, Lu PN, Zhou QF, Yuan ZX, Zhao J, Zhang M, Song ZZ, Yu JX, Guo ZY, Chen JE.

Rev Sci Instrum. 2012 Feb;83(2):02B711. doi: 10.1063/1.3670345.

PMID:
22380316
25.

A 2.45 GHz electron cyclotron resonance proton ion source and a dual-lens low energy beam transport.

Zhang WH, Ma HY, Yang Y, Wu Q, Zhang XZ, Wang H, Ma BH, Feng YC, Fang X, Guo JW, Cao Y, Li XX, Zhu YH, Li JY, Sha S, Lu W, Lin SH, Guo XH, Zhao HY, Sun LT, Xie DZ, Peng SX, Liu ZW, Zhao HW.

Rev Sci Instrum. 2012 Feb;83(2):02A329. doi: 10.1063/1.3669802.

PMID:
22380176
26.

Upgrade of the extraction system of permanent magnet electron cyclotron resonance ion source.

Zhang M, Peng SX, Ren HT, Song ZZ, Yuan ZX, Zhou QF, Lu PN, Xu R, Zhao J, Yu JX, Chen JE, Guo ZY, Lu YR.

Rev Sci Instrum. 2010 Feb;81(2):02B715. doi: 10.1063/1.3277213.

PMID:
20192455
27.

The deuteron injector progress of the Peking University Neutron Imaging Facility project.

Ren HT, Peng SX, Zhang M, Zhou QF, Song ZZ, Yuan ZX, Lu PN, Xu R, Zhao J, Yu JX, Lu YR, Guo ZY, Chen JE.

Rev Sci Instrum. 2010 Feb;81(2):02B714. doi: 10.1063/1.3273078.

PMID:
20192454
28.

Preliminary studies on space charge compensation by analyzing residual argon gas ion signals.

Lu PN, Peng SX, Ren HT, Zhang M, Yuan ZX, Song ZZ, Zhao J, Yu JX, Ma YJ, Xu R, Guo ZY.

Rev Sci Instrum. 2010 Feb;81(2):02B711. doi: 10.1063/1.3271257.

PMID:
20192451
29.

Proliferation of retinal pigment epithelial cells induced by (R,R)-XY-10 and (S,S)-XY-10 and their action mechanisms.

Cheng YW, Wang YL, Zhang YH, Peng SX, Chiou GC.

Int J Ophthalmol. 2010;3(1):9-13. doi: 10.3980/j.issn.2222-3959.2010.01.03. Epub 2010 Mar 18.

30.

[Quality of life in patients with primary congenital glaucoma following antiglaucoma surgical management].

Zhang XL, Du SL, Ge J, Chen WR, Fan Q, Peng SX, Yu MB, Liu X.

Zhonghua Yan Ke Za Zhi. 2009 Jun;45(6):514-21. Chinese.

PMID:
19957674
31.

[Advances in the study of nitric oxide-donating drugs].

Zhang YH, Peng SX.

Yao Xue Xue Bao. 2009 Nov;44(11):1200-10. Review. Chinese.

PMID:
21355319
32.

[Clinical observation of trabeculectomy for primary angle closure glaucoma].

Wang M, Ge J, Lin MK, Zhuo YH, Ling YL, Fang M, Liu X, Peng SX, Yu MB.

Zhonghua Yan Ke Za Zhi. 2009 Apr;45(4):338-43. Chinese.

PMID:
19575967
33.

[A spatial-distance analysis approach of multi-spectrum feature distribution for remote sensing image land use/cover].

Lin J, Tan YH, Yang YL, Peng SX, Liu JX.

Guang Pu Xue Yu Guang Pu Fen Xi. 2009 Feb;29(2):436-40. Chinese.

PMID:
19445222
34.

Synthesis and biological evaluation of nitric oxide-donating thalidomide analogues as anticancer agents.

Wang T, Zhang YH, Kong XW, Lai YS, Ji H, Chen YP, Peng SX.

Chem Biodivers. 2009 Apr;6(4):466-74. doi: 10.1002/cbdv.200800014.

PMID:
19353543
35.

Synthesis and cytotoxic evaluation of novel dimethyl [1,1'-biphenyl]-2,2'-dicarboxylates bearing 1,3,4-thiadiazole moieties.

Kong XW, Zhang YH, Wang T, Lai YS, Peng SX.

Chem Biodivers. 2008 Sep;5(9):1743-52. doi: 10.1002/cbdv.200890163.

PMID:
18816527
36.

Improved pharmacokinetic and bioavailability support of drug discovery using serial blood sampling in mice.

Peng SX, Rockafellow BA, Skedzielewski TM, Huebert ND, Hageman W.

J Pharm Sci. 2009 May;98(5):1877-84. doi: 10.1002/jps.21533.

PMID:
18803263
37.

Study on proton fraction of beams extracted from electron cyclotron resonance ion source.

Xu R, Zhao J, Peng SX, Yuan ZX, Song ZZ, Yu JX, Guo ZY.

Rev Sci Instrum. 2008 Feb;79(2 Pt 2):02B713. doi: 10.1063/1.2805644.

PMID:
18315204
38.

Experimental results of an electron cyclotron resonance oxygen source and a low energy beam transport system for 1 MeV integral split ring radio frequency quadruple accelerator upgrade project.

Peng SX, Zhang M, Song ZZ, Xu R, Zhao J, Yuan ZX, Yu JX, Chen J, Guo ZY.

Rev Sci Instrum. 2008 Feb;79(2 Pt 2):02B706. doi: 10.1063/1.2802200.

PMID:
18315197
39.

The influence of magnetic field configuration on an electron cyclotron resonance ion source.

Peng SX, Xu R, Zhao J, Yuan ZX, Zhang M, Song ZZ, Yu JX, Lu YR, Guo ZY.

Rev Sci Instrum. 2008 Feb;79(2 Pt 2):02A310. doi: 10.1063/1.2812343.

PMID:
18315100
40.

[A novel class of anti-inflammatory and analgesic drugs--NO-donating NSAIDs].

Zhang YH, Ji H, Peng SX.

Yao Xue Xue Bao. 2007 Apr;42(4):352-7. Review. Chinese.

PMID:
17633199
41.

[Synthesis and antithrombotic activity of acetylsalicyl ferulic acid-coupling furoxans and nitrates].

Zhou Z, Jiang LY, Zhang YH, Ji H, Sun Y, Peng SX.

Yao Xue Xue Bao. 2006 Nov;41(11):1050-6. Chinese.

PMID:
17262946
42.

[Targeting of nitric oxide-donor and related drugs].

Zhang YH, Tian JD, Peng SX.

Yao Xue Xue Bao. 2006 Jun;41(6):481-6. Review. Chinese. No abstract available.

PMID:
16927819
43.

Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A.

Peng SX, Ritchie DM, Cousineau M, Danser E, Dewire R, Floden J.

J Pharm Sci. 2006 Sep;95(9):1984-93.

PMID:
16850393
44.

Telomere length changes after umbilical cord blood transplant.

Pipes BL, Tsang T, Peng SX, Fiederlein R, Graham M, Harris DT.

Transfusion. 2006 Jun;46(6):1038-43.

PMID:
16734822
45.

Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.

Janusz MJ, Hookfin EB, Brown KK, Hsieh LC, Heitmeyer SA, Taiwo YO, Natchus MG, Pikul S, Almstead NG, De B, Peng SX, Baker TR, Patel V.

Inflamm Res. 2006 Feb;55(2):60-5.

PMID:
16612565
46.

A 96-well screen filter plate for high-throughput biological sample preparation and LC-MS/MS analysis.

Peng SX, Cousineau M, Juzwin SJ, Ritchie DM.

Anal Chem. 2006 Jan 1;78(1):343-8.

PMID:
16383347
47.

Formation of MTBE-DNA adducts in mice measured with accelerator mass spectrometry.

Du HF, Xu LH, Wang HF, Liu YF, Tang XY, Liu KX, Peng SX.

Environ Toxicol. 2005 Aug;20(4):397-401.

PMID:
16007660
48.

Structural characterization of chlorobenzylidine.

Li ZH, Ni KY, Zhou GX, Zhang C, Huang WL, Peng SX.

Yao Xue Xue Bao. 2004 Jul;39(7):546-50.

PMID:
15493848
49.

[Six novel mutations in PAH gene detected by sequencing].

Zhang Z, He YS, Peng SX, Wang FH, Jiang JH, Jing RJ, Cheng G, Xu J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Aug;21(4):305-8. Chinese.

PMID:
15300621
50.

[Studies on the chemical constituents of Cirsium japonicum DC].

Zhi F, Kong LY, Peng SX.

Yao Xue Xue Bao. 2003 Jun;38(6):442-7. Chinese.

PMID:
14513805

Supplemental Content

Support Center